Gsk Share Discussion Threads

[abdullla] 01/5/2019 12:16

Looks trouble ahead on free cash flow

[abdullla] 01/5/2019 12:09

With these results she should be dishing out caviar.

[tradermichael] 01/5/2019 08:52

Yes, but Emma will be serving tea and biscuits during the webcast at 14.00 BST

[gbh2] 01/5/2019 08:51

They need to sort out their manufacturing problems !

[abdullla] 01/5/2019 08:36

Yes you better have the tea trolley ready when the masters wake up.

[sicker] 01/5/2019 08:35

12.00 GMT last year :-)

[thamestrader] 01/5/2019 07:50

yes, but I think they wait until the US wakes up.

[jadeticl3] 01/5/2019 07:49

Are results due out today?

[tradermichael] 01/5/2019 07:05

2 weeks to next x-dividend …… ;0)

[alphorn] 30/4/2019 21:10

TM - will they all be additional sales or will some of those new sales come from existing drugs (sales)?

[crossing_the_rubicon] 30/4/2019 21:07

Some of the world’s largest drugmakers painted an optimistic picture of the industry’s prospects this year, after posting better than expected first-quarter earnings thanks to growth in China and new cancer treatments.

Pfizer, Merck and Eli Lilly all increased their earnings forecasts for 2019 on Tuesday, even as investors continue to worry about the prospect of US regulation on drug prices and US presidential candidates pledge to transform the healthcare system.



Interesting comment vis earnings forecasts UP despite fear over US regulation on drug prices.....

[tradermichael] 29/4/2019 18:23

Not sure what you mean?

[alphorn] 29/4/2019 14:01

TM - will that be incremental sales or cannibalisation?

[tradermichael] 29/4/2019 13:57

ViiV Healthcare submits New Drug Application to US FDA for the first monthly, injectable, two-drug regimen of cabotegravir and rilpivirine for treatment of HIV
If approved, cabotegravir and rilpivirine would be the first-ever long-acting, injectable treatment regimen for adults living with HIV

[tradermichael] 27/4/2019 08:39

The U.S. Food and Drug Administration on Friday said it approved GlaxoSmithKline PLC's (GSK) Benlysta, or belimumab, intravenous infusion to treat children with systemic lupus erythematosus, commonly known as lupus.
This is the first time the administration approved a treatment for pediatric patients with lupus, it said. Benlysta has been approved for use in adult patients since 2011.
The FDA said childhood-onset SLE is rare, but is generally more active in children and adolescents than adult patients. As a result of the disease starting early in life, pediatric patients have a higher risk for developing increased organ damage and complications from the disease.

[tradermichael] 25/4/2019 08:27

Shingrix is in favour, though …..

GlaxoSmithKline̵7;s new shingles vaccine Shingrix hit the market running, performing so well in its launch year that the drugmaker ran into supply constraints. In response, GSK has pledged to boost its capacity, and it's now investing $100 million in vaccine production in Montana.
GSK on Wednesday unveiled a $100 million investment to an existing site in Hamilton, Montana, where it makes adjuvants used in several of its vaccines. The expansion will add permanent jobs at the site as well as temporary construction and contracting work.
The company’s site in Hamilton, Montana currently employs around 200 people. The site has produced adjuvants for GSK vaccines for more than a decade, GSK U.S. president of pharmaceuticals Jack Bailey said in a statement.
"By expanding the adjuvant system production capabilities in Hamilton, we will continue to deliver long-term and sustainable supply for key vaccines, including Shingrix,” Bailey added.

The investment comes after a huge launch year for Shingrix, during which the vaccine pulled in £784 million ($1 billion). Execs have committed to continue expanding production capacity to avoid last year's supply issues. In response to short supply, the company delayed TV advertising and implemented order limits for its vaccines.
As of the end of December, GSK has distributed more than 8.5 million doses of the vaccine, a spokesman said. The company plans to ship a "significantly" higher number of doses this year. On a conference call last year, GSK's global pharmaceuticals president Luke Miels said the company can "pretty much sell anything that we can make now in the U.S."

[montyhedge] 24/4/2019 14:49

Pharma's are so out of favour in the US, price going lower boys.

[tradermichael] 24/4/2019 11:39

3 weeks to ex-dividend …… ;0)

[philanderer] 18/4/2019 23:17

Market report:

Drug makers dragged on the FTSE 100, which ended down 0.2 per cent or 11.44 points, at 7459.88, after healthcare reform proposals from US Democratic presidential candidates sparked a sell-off.

[zho] 18/4/2019 11:26

Redundancies are being made at pharmaceutical giant GlaxoSmithKline in Stevenage as part of “a new approach to research and development”.

[alphorn] 18/4/2019 11:24

Read last night somewhere about redundancies in Stevenage?

[jadeticl3] 17/4/2019 14:02

I will do so Toffeeman if I don’t get a sensible reply from buywell.